U.S. Markets open in 2 hrs 18 mins

Shire plc (SHPG)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
174.92+4.17 (+2.44%)
At close: 4:00PM EDT

173.13 -1.79 (-1.02%)
Pre-Market: 7:08AM EDT

People also watch
ALXNJAZZBMRNREGNBAX
Full screen
Previous Close170.75
Open173.68
Bid173.41 x 300
Ask173.58 x 100
Day's Range173.30 - 176.32
52 Week Range161.09 - 209.22
Volume300
Avg. Volume1,084,820
Market Cap52.53B
Beta1.73
PE Ratio (TTM)179.41
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.91 (0.53%)
Ex-Dividend Date2017-03-08
1y Target EstN/A
Trade prices are not sourced from all markets
  • Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
    Zacks20 hours ago

    Shire (SHPG) Receives MAA Validation for Veyvondi by EMA

    Shire plc (SHPG) announced that the European Medicines Agency (EMA) validated the Marketing Authorization Application (MAA) for Veyvondi to prevent and treat bleeding episodes and peri-operative bleeding in adults diagnosed with von Willebrand Disease.

  • TheStreet.com22 hours ago

    Biotech Movers: Shire, Bellicum, Organovo

    Shire, Bellicum Pharmaceuticals and Organovo Holdings were among the biotech stock movers in premarket trading on June 22.

  • Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US
    Zacks2 days ago

    Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US

    Shire Plc (SHPG) announced that the FDA has approved its new attention deficit hyperactivity disorder (ADHD) drug, Mydayis (mixed salts of a single-entity amphetamine product) in patients 13 years and older